Cubist Systematic Strategies’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Cubist Systematic Strategies’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$107K	Sell	5,300 -77,800	-94%	-$1.37M	﹤0.01%	2766
2025 Q2	$1.39M	Buy	+83,100	New	+$1.34M	0.01%	1760
2024 Q1	–	Sell	-18,300	Closed	-$191K	–	4262
2023 Q4	$191K	Hold	18,300	–	–	﹤0.01%	3020
2023 Q3	$187K	Hold	18,300	–	–	﹤0.01%	2809
2023 Q2	$138K	Sell	18,300 -78,000	-81%	-$632K	﹤0.01%	2918
2023 Q1	$852K	Sell	96,300 -23,200	-19%	-$229K	0.01%	2298
2022 Q4	$1.09M	Buy	+119,500	New	+$1.04M	0.01%	2367

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Cubist Systematic Strategies's TEVA Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2024, closing a stake of 190,244 shares — an estimated $3.43M sold.

Cubist Systematic Strategies first reported a position in TEVA in Q2 2014 and held it in 41 quarters. The position peaked at $8.96M in Q2 2023. 584 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

Cubist Systematic Strategies reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 190,244 Teva Pharmaceutical Industries Limited shares in Q4 2024, an estimated $3.43M.
Cubist Systematic Strategies first reported a position in Teva Pharmaceutical Industries Limited in Q2 2014 and held it in 41 quarters.
Cubist Systematic Strategies's Teva Pharmaceutical Industries Limited position peaked at $8.96M in Q2 2023.
584 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.